These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Control of Ca2+ influx by manipulation of Ca2+ and/or Ca2+ antagonist in cardioplegic arrest.
    Author: Hashimoto K, Hahimoto K [corrected to Hashimoto K], Mashburn JP, Cartier R, Schaff HV.
    Journal: Jpn Circ J; 1993 Mar; 57(3):237-44. PubMed ID: 8385232.
    Abstract:
    Maximum deactivation of the contractile elements using Ca2+ minimizes oxygen requirements during global ischemia, Ca2+ antagonists and Ca(2+)-free cardioplegia solutions are methods by which the Ca2+ flux can be manipulated. This study was performed with 5 experimental groups: 1) Standard cardioplegia (with Ca2+), 2) Ca(2+)-free cardioplegia, 3) Ca(2+)-free cardioplegia plus verapamil (0.5 mg/L), 4) Verapamil cardioplegia (with Ca2+), and 5) Ca(2+)-free cardioplegia, in which verapamil was administered at the onset of reperfusion (0.5 mg/L). Cardiac functions, heart rate, edema formation, and creatine kinase concentration were measured before and after 70 min of ischemia at a myocardial temperature of 20 degrees C. Ca(2+)-free cardioplegia may be beneficial under hypothermic conditions, but the "Ca2+ paradox" was still a matter of concern. Reperfusion with verapamil did not protect from reperfusion-related injuries. However, the use of verapamil provided more protection than did standard or Ca(2+)-free cardioplegic solutions. Since verapamil did not maintain membrane integrity during ischemia when combined with Ca(2+)-free cardioplegic solutions (prominent edema formation was observed), its combination with Ca(2+)-containing cardioplegic solutions is recommended.
    [Abstract] [Full Text] [Related] [New Search]